Catherine Daniel

Summary

Affiliation: Institut de Biologie de Lille
Country: France

Publications

  1. pmc Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model
    Catherine Daniel
    Laboratoire des Bactéries Lactiques et Immunité des Muqueuses, Institut Pasteur de Lille, 59019 Lille Cedex, France
    Appl Environ Microbiol 72:5799-805. 2006
  2. pmc Bioluminescence imaging study of spatial and temporal persistence of Lactobacillus plantarum and Lactococcus lactis in living mice
    Catherine Daniel
    Institut Pasteur de Lille, Lactic acid Bacteria and Mucosal Immunity, Center for Infection and Immunity of Lille, Lille, France
    Appl Environ Microbiol 79:1086-94. 2013
  3. doi request reprint Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV
    Catherine Daniel
    Laboratoire des Bactéries Lactiques et Immunité des Muqueuses, Institut Fédératif de Recherche 142, Institut Pasteur de Lille, Lille F 59021, France
    Vaccine 27:1141-4. 2009
  4. doi request reprint Recombinant lactic acid bacteria as mucosal biotherapeutic agents
    Catherine Daniel
    Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Universite Lille Nord de France, CNRS, UMR 8204, Institut National de la Sante et de la Recherche Medicale, U1019, F 59019 Lille, France
    Trends Biotechnol 29:499-508. 2011
  5. doi request reprint Chronic ingestion of cadmium and lead alters the bioavailability of essential and heavy metals, gene expression pathways and genotoxicity in mouse intestine
    Jerome Breton
    Bactéries Lactiques and Immunité des Muqueuses, Centre d Infection et d Immunité de Lille, Institut Pasteur de Lille, INSERM U 1019, CNRS UMR 8204, Universite Lille Nord de France, 1 rue du Pr Calmette, BP 245, 59019, Lille, France
    Arch Toxicol 87:1787-95. 2013
  6. ncbi request reprint Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein
    Benoit Foligne
    Laboratoire des Bactéries Lactiques et Immunité des Muqueuses, Institut Pasteur de Lille, Lille, France
    Gastroenterology 133:862-74. 2007
  7. pmc Snapshot on a Pilot Metagenomic Study for the Appraisal of Gut Microbial Diversity in Mice, Cat, and Man
    Coline Ple
    Université Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Centre d Infection et d Immunité de Lille, 59000 Lille, France
    Gastroenterol Res Pract 2016:6587825. 2016
  8. pmc Dual-Color Bioluminescence Imaging for Simultaneous Monitoring of the Intestinal Persistence of Lactobacillus plantarum and Lactococcus lactis in Living Mice
    Catherine Daniel
    Lactic Acid Bacteria and Mucosal Immunity Team, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France Université de Lille, Lille, France CNRS, UMR 8204, Lille, France
    Appl Environ Microbiol 81:5344-9. 2015
  9. doi request reprint Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis
    Catherine Daniel
    Univ Lille, INSERM, CNRS, CHU Lille, Institut Pasteur de Lille, U1019 UMR 8204 CIIL Center for Infection and Immunity of Lille, F 59000 Lille, France
    Vaccine 34:5762-5767. 2016
  10. doi request reprint Understanding immunomodulatory effects of probiotics
    Bruno Pot
    Laboratory for Lactic Acid Bacteria and Mucosal Immunity, Center for Infection and Immunity Lille, Institut Pasteur de Lille, INSERM U1019 CNRS UMR 8204 University Lille Nord de France, Lille, France
    Nestle Nutr Inst Workshop Ser 77:75-90. 2013

Collaborators

  • Florent Sebbane
  • Nadine Lemaitre
  • Jean Claude Sirard
  • Corinne Grangette
  • Michiel Kleerebezem
  • Michael Marceau
  • Jean Fioramonti
  • P Hols
  • Benoit Foligne
  • Jerome Breton
  • Coline Ple
  • Bruno Pot
  • Nathalie Adele-Dit-Renseville
  • Stéphanie Ferreira
  • Louise Eva Vandenborght
  • Mathieu Sauty
  • Joelle Dewulf
  • Patrick Thomas
  • Andreas Repa
  • Nathalie Guriec
  • Sean Hanniffy
  • Annick Mercenier
  • Ursula Wiedermann
  • Mathilde Body-Malapel
  • Anne Garat
  • Cecile Vignal
  • Foligné Benoît
  • Christophe Carnoy
  • Sylvie Penet
  • Fabrice Nesslany
  • Thierry Chassat
  • Lauren Nakab
  • Kelly Le Clère
  • Stéphanie Pothion
  • Nathalie Froux
  • Elisabeth Hardy
  • Christian Berthou
  • Karine Le Ster
  • Jerry Wells
  • Helena Tlaskolova
  • Søren Madsen
  • Peter Bron
  • Jean Delcour
  • Astrid Vrang
  • Hans Israelsen
  • Hana Kozakova
  • Karin Hoffmann-Sommergruber
  • Heimo Breiteneder
  • Romana Hochreiter
  • Dietrich Kraft
  • Josef Thalhamer

Detail Information

Publications20

  1. pmc Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model
    Catherine Daniel
    Laboratoire des Bactéries Lactiques et Immunité des Muqueuses, Institut Pasteur de Lille, 59019 Lille Cedex, France
    Appl Environ Microbiol 72:5799-805. 2006
    ..We conclude that not all lactobacilli have similar effects on intestinal inflammation and that selected probiotics such as L. salivarius Ls-33 may be considered in the prevention or treatment of intestinal inflammation...
  2. pmc Bioluminescence imaging study of spatial and temporal persistence of Lactobacillus plantarum and Lactococcus lactis in living mice
    Catherine Daniel
    Institut Pasteur de Lille, Lactic acid Bacteria and Mucosal Immunity, Center for Infection and Immunity of Lille, Lille, France
    Appl Environ Microbiol 79:1086-94. 2013
    ..The application of luciferase-labeled bacteria has significant potential to allow the in vivo and ex vivo study of the interactions of lactic acid bacteria with their mammalian host...
  3. doi request reprint Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV
    Catherine Daniel
    Laboratoire des Bactéries Lactiques et Immunité des Muqueuses, Institut Fédératif de Recherche 142, Institut Pasteur de Lille, Lille F 59021, France
    Vaccine 27:1141-4. 2009
    ..pseudotuberculosis infections. This constitutes the first proof of principle for a novel anti-Yersinia mucosal vaccination strategy using recombinant lactic acid bacteria...
  4. doi request reprint Recombinant lactic acid bacteria as mucosal biotherapeutic agents
    Catherine Daniel
    Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Universite Lille Nord de France, CNRS, UMR 8204, Institut National de la Sante et de la Recherche Medicale, U1019, F 59019 Lille, France
    Trends Biotechnol 29:499-508. 2011
    ..In this review, we provide a timely update on the recent important advances made in this field, and outline the potential of recombinant LAB as therapeutic tools for their safe and efficient use in human health...
  5. doi request reprint Chronic ingestion of cadmium and lead alters the bioavailability of essential and heavy metals, gene expression pathways and genotoxicity in mouse intestine
    Jerome Breton
    Bactéries Lactiques and Immunité des Muqueuses, Centre d Infection et d Immunité de Lille, Institut Pasteur de Lille, INSERM U 1019, CNRS UMR 8204, Universite Lille Nord de France, 1 rue du Pr Calmette, BP 245, 59019, Lille, France
    Arch Toxicol 87:1787-95. 2013
    ..Collectively, it provides useful information for the risk assessment of heavy metals in gut homeostasis and further disease's susceptibility. ..
  6. ncbi request reprint Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein
    Benoit Foligne
    Laboratoire des Bactéries Lactiques et Immunité des Muqueuses, Institut Pasteur de Lille, Lille, France
    Gastroenterology 133:862-74. 2007
    ....
  7. pmc Snapshot on a Pilot Metagenomic Study for the Appraisal of Gut Microbial Diversity in Mice, Cat, and Man
    Coline Ple
    Université Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Centre d Infection et d Immunité de Lille, 59000 Lille, France
    Gastroenterol Res Pract 2016:6587825. 2016
    ..Both interindividual and time-related variations are demonstrated and discussed. ..
  8. pmc Dual-Color Bioluminescence Imaging for Simultaneous Monitoring of the Intestinal Persistence of Lactobacillus plantarum and Lactococcus lactis in Living Mice
    Catherine Daniel
    Lactic Acid Bacteria and Mucosal Immunity Team, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France Université de Lille, Lille, France CNRS, UMR 8204, Lille, France
    Appl Environ Microbiol 81:5344-9. 2015
    ..The application of dual-luciferase-labeled bacteria has considerable potential to simultaneously study the interactions and potential competitions of different targeted bacteria and their hosts. ..
  9. doi request reprint Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis
    Catherine Daniel
    Univ Lille, INSERM, CNRS, CHU Lille, Institut Pasteur de Lille, U1019 UMR 8204 CIIL Center for Infection and Immunity of Lille, F 59000 Lille, France
    Vaccine 34:5762-5767. 2016
    ..pseudotuberculosis infection. Here, we aimed at characterizing the immunological basis of this LcrV-elicited protective response and at determining the duration of vaccine-induced immunity...
  10. doi request reprint Understanding immunomodulatory effects of probiotics
    Bruno Pot
    Laboratory for Lactic Acid Bacteria and Mucosal Immunity, Center for Infection and Immunity Lille, Institut Pasteur de Lille, INSERM U1019 CNRS UMR 8204 University Lille Nord de France, Lille, France
    Nestle Nutr Inst Workshop Ser 77:75-90. 2013
    ..Only then can the proper clinical trials with proper readouts be set up to prove efficacy of each strain/mixture individually...
  11. ncbi request reprint Therapeutic potential of Yersinia anti-inflammatory components
    Benoit Foligne
    Inserm U801, Faculté de Médecine Institut Pasteur de Lille, Universite de Lille, France
    Adv Exp Med Biol 603:361-6. 2007
    ..This is the case for virulence plasmid-encoded proteins from pathogenic Yersiniae that inhibit the host's inflammatory response by interfering with various cellular signaling pathways...
  12. pmc Corrigendum to "Snapshot on a Pilot Metagenomic Study for the Appraisal of Gut Microbial Diversity in Mice, Cat, and Man"
    Coline Ple
    Université Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Centre d Infection et d Immunité de Lille, 59000 Lille, France
    Gastroenterol Res Pract 2016:3053727. 2016
    ..This corrects the article DOI: 10.1155/2016/6587825.]. ..
  13. pmc Does oral exposure to cadmium and lead mediate susceptibility to colitis? The dark-and-bright sides of heavy metals in gut ecology
    Jerome Breton
    Univ Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 UMR 8204 CIIL Centre d Infection et d Immunité de Lille, F 59000 Lille, France
    Sci Rep 6:19200. 2016
    ..The possible adaptive and immunosuppressive mechanisms by which heavy metals might reduce intestinal inflammation are explored and discussed. ..
  14. doi request reprint Probiotics from research to market: the possibilities, risks and challenges
    Benoit Foligne
    Institut Pasteur de Lille, Lactic acid Bacteria and Mucosal Immunity, Center for Infection and Immunity of Lille, 1, rue du Pr Calmette, BP 245, F 59019 Lille, France
    Curr Opin Microbiol 16:284-92. 2013
    ..This review discusses the crosstalk between probiotic producers, regulatory people, medical care and healthcare workers, and the scientific community. ..
  15. doi request reprint Gut microbiota limits heavy metals burden caused by chronic oral exposure
    Jerome Breton
    Bactéries Lactiques and Immunité des Muqueuses, Centre d Infection et d Immunité de Lille, Institut Pasteur de Lille, INSERM U 1019, CNRS UMR 8204 Université Lille Nord de France, 1 rue du Pr Calmette, BP 245, F 59019 Lille, France
    Toxicol Lett 222:132-8. 2013
    ..Collectively, these data illustrate the complex host-microbes interplay occurring with environmental pollutants inside the gut. ..
  16. doi request reprint Maintaining gut ecosystems for health: Are transitory food bugs stowaways or part of the crew?
    Coline Ple
    Center for Infection and Immunity of Lille, Institut Pasteur de Lille, Team Lactic Acid Bacteria and Mucosal Immunity, Inserm U1019, CNRS UMR 8204, University of Lille, 1 rue du Pr Calmette, BP 245, F 59019 Lille, France
    Int J Food Microbiol 213:139-43. 2015
    ..In particular, the key role of microbial strains as part of food ecosystems for health and diseases is discussed through the prism of fermented dairy products and gut inflammation. ..
  17. ncbi request reprint Potential and opportunities for use of recombinant lactic acid bacteria in human health
    Sean Hanniffy
    Institute of Food Research, Norwich Research Park, Colney, Norwich, NR4 7UA, United Kingdom
    Adv Appl Microbiol 56:1-64. 2004
  18. ncbi request reprint Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy
    Andreas Repa
    Department of Pathophysiology, Medical School AKH EBO3Q, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Vaccine 22:87-95. 2003
    ..We conclude that these LAB strains in combination with an allergen could be promising candidates for mucosal vaccination against type I allergy...
  19. ncbi request reprint Cytokine-regulated expression and inhibitory function of FcgammaRIIB1 and -B2 receptors in human dendritic cells
    Nathalie Guriec
    Cellular Therapy Laboratory, Brest Medical School, France
    J Leukoc Biol 79:59-70. 2006
    ..Altogether, our results evidence an inhibitory role for FcgammaRIIB in human DC and provide an easy way to possibly improve in vitro the induction of immune response against IC-linked antigen...
  20. ncbi request reprint Use of a pleural implantable access system for the management of malignant pleural effusion: the Institut Curie experience
    Catherine Daniel
    Institut Curie, Paris, France
    Ann Thorac Surg 84:1367-70. 2007
    ..The authors report the first experience of a pleural implantable access system for the treatment of recurrent symptomatic malignant pleural effusion...